Effect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant

References

• Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010;14(4):CD003481.
   Google Scholar
• Cooper-Peel C, Brodersen R, Robertson A. Does ibuprofen affect bilirubin-albumin binding in newborn infant serum?? Pharmacol Toxicol 1996;79:297–299.
   PubMedGoogle Scholar
• Ahlfors CE. Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 2004;144:386–388.
   PubMed Web of Science ®Google Scholar
• Ambat MT, Ostrea EM Jr, Aranda JV. Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays. J Perinatol 2008;28:287–290.
   PubMed Web of Science ®Google Scholar
• Soligard HT, Nilsen OG, Bratlid D. Displacement of bilirubin from albumin by ibuprofen in vitro. Pediatr Res 2010;67:614–618.
   PubMed Web of Science ®Google Scholar
• Brodersen R, Ebbesen F. Bilirubin-displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants.J Pharm Sci 1983;72:248–253.
   PubMed Web of Science ®Google Scholar
• Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med 2006;8:513–529.
   PubMed Web of Science ®Google Scholar
• Hankø E, Tommarello S, Watchko JF, Hansen TW. Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain. Pediatr Res 2003;54:441–445.
   PubMed Web of Science ®Google Scholar
• Mansi G, De Maio C, Araimo G, Rotta I, Crivaro V, Sarno M, Raimondi F, Paludetto R. “Safe” hyperbilirubinemia is associated with altered neonatal behavior. Biol Neonate 2003;83:19–21.
   PubMedGoogle Scholar
• Okumura A, Kidokoro H, Shoji H, Nakazawa T, Mimaki M, Fujii K, Oba H, Shimizu T. Kernicterus in preterm infants. Pediatrics 2009;123:e1052–e1058.
   PubMed Web of Science ®Google Scholar
• Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ, Ehrenkranz RA, et al.; National institute of child health and human development neonatal research network. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003;112:773–779.
   PubMed Web of Science ®Google Scholar
• Van de Bor M, Ens-Dokkum M, Schreuder AM, Veen S, Brand R, Verloove-Vanhorick SP. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics 1992;89:359–364.
   PubMed Web of Science ®Google Scholar
• Bender GJ, Cashore WJ, Oh W. Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 2007;120:1067–1073.
   PubMed Web of Science ®Google Scholar
• Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991;80:1119–1127.
   PubMed Web of Science ®Google Scholar
• Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem 1974;20:783.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE, Vreman HJ, Wong RJ, Bender GJ, Oh W, Morris BH, Stevenson DK. Phototherapy subcommittee; national institute of child health and development (NICHD) neonatal research network. Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns. Clin Biochem 2007;40:261–267.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 2000;279:130–135.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE. Unbound bilirubin associated with kernicterus: a historical approach.J Pediatr 2000;137(4):540–544.
   PubMed Web of Science ®Google Scholar
• Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H, Papageorgiou A, Chemtob S. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997;86:289–293.
   PubMed Web of Science ®Google Scholar
• Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, Carlo WA, et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of non-symptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009;26:235–245.
   PubMed Web of Science ®Google Scholar
• Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 2005;30:121–132.
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Touw D, Schepens PJ, Kearns GL, Van den Anker JN. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther 2001;70:336–343.
   PubMed Web of Science ®Google Scholar
• Desfrere L, Mourdie J, Barbier A, Moriette G. Effect of ibuprofen on unbound bilirubin levels in preterm newborns. In: PAS annual meeting 2007; Toronto, Canada:8447.1.
   Google Scholar
• Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, et al.Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939–1944.
   PubMed Web of Science ®Google Scholar
• Pees C, Walch E, Obladen M, Koehne P. Echocardiography predicts closure of patent ductus arteriosus in response to ibuprofen in infants less than 28 week gestational age. Early Hum Dev 2010;86:503–508.
   PubMed Web of Science ®Google Scholar
• Diot C, Kibleur Y, Desfrere L. Effect of ibuprofen on bilirubin-albumin binding in vitro at concentrations observed during treatment of patent ductus arteriosus. Early Hum Dev 2010;86:315–317.
   PubMed Web of Science ®Google Scholar
• Koehne PS, Hüseman D, Walch E, Schuelke M, Varon R, Karbasiyan M, Aust G, Obladen M. Genetic deafness in a preterm infant with a critical postnatal course. Pediatr Crit Care Med 2006;7:270–272.
   PubMed Web of Science ®Google Scholar
• Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants. Acta Paediatr 2009;98:36–42.
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Vanhagendoren S, Schepens P, Ahlfors C. The influence of Ibuprofen-lysine on unbound bilirubin plasma levels in preterm neonates [Abstract]. In: PAS annual meeting 2004; San Francisco, CA:2687.
   Google Scholar